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Background
Subjects with a history of documented penicillin allergy
but with negative skin test results for cephalosporins, can
tolerate subsequent challenge doses of cephalosporin with-
out an allergic reaction. [1]. In immediate reactions to
betalactams (BL), in some instances, specificity was mainly
directed to the BL inducing the reaction, but in other
cases specificity was mainly directed to another structure,
probably related with previous BL exposure [2].
Methods
Between November 2011 and October 2013, we prospec-
tively recruited a total population of 100 (71 women,
29 men) patients from the outpatients of the Clinical
Immunology Unit (Florence, Italy). Patients had a history
of immediate reactions to at least one penicillin (Tab. 1)
and positive results on skin tests for one or more penicillin
reagents (penicilloyl-polylysine, minor determinant mix-
ture, and benzylpenicillin), one or more semi-synthetic
penicillins (amoxicillin, ampicillin), or both [3]. We also
evaluated sensitization to cephalosporins by using skin
tests [4] with second-generation (cefuroxime), and third-
generation (ceftazidime, ceftriaxone, and cefotaxime)
cephalosporins. In cases of negative results for all of these
cefalosporins, cefuroxime and ceftriaxone were adminis-
tered to consenting patients [1].
Results
74 of the 100 patients underwent challenges with oral
cefuroxime axetil and intramuscular ceftriaxone: all tol-
erated the challenge. After about a month we repeated
the skin tests with PPL, MDM, and the two cephalos-
porins administered (cefuroxime and ceftriaxone).
8 patients (10.8%) presented new sensitizations: 2 for
MDM, 2 for PPL and MDM, 1 for cefuroxime, 1 for cef-
triaxone, 1 for PPL and ceftriaxone, 1 for PPL, MDM,
cefuroxime and ceftriaxone. 26 patients refused the dou-
ble challenge and only underwent a tolerance to cefur-
oxime axetil test. In one of these the challenge was
positive. The skin tests after a month with PPL, MDM,
and the cephalosporin administered (cefuroxime) pre-
sented new sensitizations in only one patient (4.0%),
for PPL.
Conclusion
One month after the challenge, the percentage of sensiti-
zation seems to be higher in patients who underwent tol-
erance tests with two cephalosporins. It would be useful to
have more data available to confirm the above mentioned
assumptions, but above all it would be useful to know if
we can recommend the cephalosporins tolerated with
negative skin tests after a month, even if associated with
positive PPL and/or MDM and/or other cephalosporin
administered with the tolerance test.
Published: 18 July 2014
doi:10.1186/2045-7022-4-S3-P64
Cite this article as: Testi et al.: Usefulness of skin tests in penicillin-
allergic patients after cephalosporins challenge. Clinical and Translational
Allergy 2014 4(Suppl 3):P64.
Azienda Sanitaria di Firenze, San Giovanni di Dio Hospital, Allergy and
Clinical Immunology Unit, Italy
Testi et al. Clinical and Translational Allergy 2014, 4(Suppl 3):P64
http://www.ctajournal.com/content/4/S3/P64
© 2014 Testi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
